Breakthrough in Sleep Apnea Management
The FDA has marked a historic milestone by approving the first pharmaceutical treatment option for certain patients with obstructive sleep apnea. Dr. Sally Seymour, director of the FDA’s division of…
Circular, maker of smart ring technology, announced its next-generation wearable, the Ring 2, which includes ECG capability with its FDA-cleared AFib detection algorithm that provides real-time heart health data to wearers. The titanium Ring 2…
Continue Reading
I would say what I have learned very quickly is that how important is health and the value of sleep. Because, if you sleep well, if you’re rested, if you understand physiology, then you…
Continue Reading
Obstructive sleep apnea (OSA) is a serious, chronic sleep-related breathing disease that impacts an estimated 80 million people in the United States and nearly 1 billion globally. Untreated OSA carries profound health and quality-of-life…
Continue Reading
This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in December. Here is…
Continue Reading
Welcome to the December edition of Digital Health Digest!In this episode, we highlight key developments in digital health, from a major AI acquisition to youth mental health initiatives, wearable health advancements, and significant funding…
Continue Reading
QALO, a company that makes silicon rings, announced the release of its health-tracking ring QRNT equipped with nano technology.The ring combines silicone material with health-tracking features, including measuring heart rate, oxygen saturation, heart rate…
Continue Reading
ŌURA, a wearable device company, has secured $200 million in Series D funding to expand its product offerings, the company announced last week.
ŌURA, which was founded in Finland in 2013, offers a wearable smart…
Continue Reading
What You Should Know:
– ŌURA, the company behind the world’s leading smart ring, has announced the completion of a $200 million Series D funding round, raising its valuation to $5.2B.
– This significant investment, with…
Continue Reading
WellTheory, a digital health company addressing autoimmune disease, launched a women’s health program on Tuesday to support those battling hormonal conditions like endometriosis, polycystic ovary syndrome, postpartum, hypothyroidism and menopause.
Atherton, California-based WellTheory treats autoimmune…
Continue Reading
